This page shows the latest binge eating disorder news and features for those working in and with pharma, biotech and healthcare.
The FDA has agreed a regulatory route for Shire's attention deficit hyperactivity disorder (ADHD) product for adults, potentially opening up a lucrative new market for the company's franchis e. ... Breaking into the adult ADHD - as well as a sideways
Seles recently admitted to experiencing binge eating disorder when she was a professional tennis player in the 1990s. ... There is a misconception that adults with binge eating disorder fit a certain profile,” said Seles.
Vyvanse already available as ADHD treatment. Shire's big-selling Vyvanse brand has become the first drug approved in the US to help people with binge-eating disorder. ... Binge eating disorder is not just about eating a lot; it is that, plus being out of
Shire is planning a marketing application in binge-eating in the third quarter, which, if approved, would be the first FDA-backed drug for the condition, potentially adding tens of millions ... Shire wants to achieve with binge-eating disorder what it
Company drops Vyvanse for use in major depressive disorder. Shire's hopes to expand the uses of its big-selling behavioural medicine Vyvanse were dashed after the drug disappointed in a ... of adults with binge eating disorder.
attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and dextroamphetamine). ... Russell highlighted developments, such as potential new indications for Vyvanse, including major depressive disorder, binge eating disorder and
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...